2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
GI
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatellite Stable mCRC - Assessing Efficacy in Non-Liver Metastatic Sites"
FEATURING
Andrea Bullock
- 141 views
- August 1, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Adenocarcinoma - Early Results From the PASS-01 Trial"
FEATURING
Jennifer Knox
- 183 views
- July 9, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"
FEATURING
Cathy Eng
- 212 views
- July 9, 2024
- 2
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Cancer, NSCLC, HCC, and Upper-GI Cancers"
- 192 views
- July 9, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NETTER-2 Study - Efficacy and Safety of 177Lu-DOTA-TATE in Newly Diagnosed Advanced Grade 2/3 Gastroenteropancreatic NETs"
FEATURING
Philip Philip
- 97 views
- July 8, 2024
COR2ED The Heart of Medical Education
ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophageal and Colorectal Cancers"
- 222 views
- July 8, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EA2174 Study - Peri-Operative Nivo & Ipi for Locoregional Esophageal & GEJ Adenocarcinoma"
FEATURING
Michael Gibson
- 92 views
- July 5, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aHCC - Outcomes Based on Child Pugh and ALBI Liver Function"
FEATURING
Michael Storandt
- 88 views
- July 1, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including TRANSMET and ARC-9 Trials"
- 362 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxel vs. 5-FU, Leucovorin, & Liposomal Irinotecan in Older Pts With Treatment-Naïve Metastatic Pancreatic Cancer"
FEATURING
Efrat Dotan
- 753 views
- June 7, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancers Including ESOPEC and ARMANI Trials"
- 557 views
- June 10, 2024
- 4
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"
FEATURING
Harry Yoon
- 157 views
- June 6, 2024
- 3
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Updates in Gastroesophageal Cancers"
FEATURING
Aditya Shreenivas,
Sakti Chakrabarti
- 138 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "212Pb-DOTAMTATE, a Targeted Alpha Therapy for Pts With Unresectable or Metastatic SSTR+ GEP-NETs"
FEATURING
Jonathan Strosberg
- 210 views
- June 6, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Updates in Colorectal Cancer"
FEATURING
Sakti Chakrabarti,
Aditya Shreenivas
- 406 views
- June 26, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Highlights in Biliary Tract Cancer"
FEATURING
Arndt Vogel
- 111 views
- June 25, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro in mPDAC"
FEATURING
Benjamin Weinberg
- 198 views
- June 6, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES-310 Studies"
FEATURING
Arndt Vogel
- 255 views
- June 25, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Updates in Frontline Management of GE Cancers - Beyond PD-1"
FEATURING
Raghav Sundar
- 151 views
- June 25, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Upper-GI Key Studies Including ESOPEC and RENAISSANCE"
FEATURING
Richard Kim,
Rutika Mehta
- 168 views
- June 21, 2024
- 3
ecancer
ASCO® 2024 Insights: "Comparing Preoperative Chemo to Neoadjuvant CRT in Patients With Esophageal Adenocarcinoma"
FEATURING
Jens Hoeppner
- 67 views
- June 21, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer Including CheckMate 9DW and ABC-07 Trials"
- 243 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"
FEATURING
Richard Kim,
Tiago Biachi
- 412 views
- June 20, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "CRC Key Studies Including TRANSMET, CheckMate 8HW, NEOPRISM, and PanaMa"
FEATURING
Richard Kim,
Tiago Biachi
- 588 views
- June 20, 2024
- 5
ecancer
ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel in De Novo Metastatic PDAC"
FEATURING
Jennifer Knox
- 201 views
- June 20, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Time Dependency for HPV ctDNA Detection as a Prognostic Biomarker for Anal Cancer"
FEATURING
Van Morris
- 37 views
- June 19, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "GABARNANCE Trial - Gemcitabine + nab-Paclitaxel vs. CRT With S-1 as Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer"
FEATURING
Masafumi Ikeda
- 41 views
- June 18, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Advancing GI Cancer Treatment - The Clinical Utility of ctDNA"
FEATURING
Stacey Cohen
- 359 views
- June 17, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With or Without Panitumumab in RAS Wild-Type mCRC"
FEATURING
Dominik Modest
- 312 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Trial - ctDNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer"
FEATURING
Jeanne Tie
- 576 views
- June 5, 2024
- 6
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Efficacy, Safety, and PD of CM24 With Nivo & Chemo in Advanced/Metastatic Pancreatic Cancer"
FEATURING
Teresa Macarulla
- 149 views
- June 5, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Atezolizumab & Varlilumab (CDX-1127) +/- Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer"
FEATURING
Thatcher Heumann
- 45 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NEOPRISM-CRC Trial - Neoadjuvant Pembro Stratified to TMB for High-Risk Stage 2 or 3 dMMR/MSI-High CRC"
FEATURING
Kai-Keen Shiu
- 94 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Refining Treatment in Advanced Hepatobiliary Cancers"
FEATURING
Laura Goff
- 128 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "FIH Trial of M9140, an Anti-CEACAM5 ADC With Exatecan Payload, in Pts With mCRC"
FEATURING
Scott Kopetz
- 105 views
- June 12, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "NETTER-2 Study - Safety & TTR of [177Lu]Lu-DOTATATE in Pts With Newly Diagnosed Advanced Grade 2 & 3, Well-Differentiated Gastroenteropancreatic NETs"
FEATURING
Pamela Kunz
- 45 views
- June 12, 2024
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Randomized ARC-9 Study to Evaluate Etrumadenant-Based Combinations in Previously-Treated mCRC"
FEATURING
Zev A. Wainberg
- 73 views
- June 10, 2024
- 2
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ARMANI Trial - Ramucirumab + Paclitaxel as Switch Maintenance vs. Continuation of Oxaliplatin-Based Chemo in Patients With Advanced HER2- GC/GEJC"
FEATURING
Filippo Pietrantonio
- 104 views
- June 10, 2024
- 1
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "CheckMate 8HW Trial - Nivo + Ipi With Chemo in 1L MSI-H/dMMR mCRC"
FEATURING
Heinz-Josef Lenz
- 74 views
- June 10, 2024
- 1